Top Opdivo Manufacturers for Advanced Cancer Treatments

Finding the right manufacturer for Opdivo can feel like searching for a needle in a haystack. With so many options, how do you ensure you’re partnering with the best? Choosing the right supplier is crucial—it impacts everything from product quality to timely delivery. A top factory can streamline your operations and enhance your reputation in the market. Imagine the peace of mind that comes with knowing your supplier meets the highest standards and can scale with your needs.

Ready to uncover the top 30 Opdivo manufacturers that can elevate your business? Let’s dive in and find the perfect match for your needs!

Top 18 Opdivo Manufacturer Manufacturers

Opdivo – Advanced Cancer Treatment Solutions

Domain: opdivo.com

Registered: 2012 ( 13 years )

Introduction: OPDIVO® (nivolumab) is a prescription medicine used for the treatment of certain types of advanced cancers, including non-small cell lung cancer (NSCLC), melanoma, and renal cell carcinoma, administered as an intravenous infusion or subcutaneous injection.

Opdivohcp – Cancer Immunotherapy Treatments

Domain: opdivohcp.com

Registered: 2014 ( 11 years )

Introduction: OPDIVO® (nivolumab) and OPDIVO Qvantig™ (nivolumab + hyaluronidase-nvhy) are immunotherapy treatments indicated for various cancers, including non-small cell lung cancer, advanced renal cell carcinoma, and gastric cancers.

Buyandbill – OPDIVO Cancer Treatment Solutions

Domain: buyandbill.com

Registered: 2011 ( 14 years )

Introduction: OPDIVO is a cancer treatment drug manufactured by Bristol Myers Squibb, classified as an antineoplastic monoclonal antibody. It is administered intravenously and is available in single-dose vials.

Drugs.com – Cancer Treatment Solutions

Domain: drugs.com

Registered: 1998 ( 27 years )

Introduction: Opdivo (nivolumab) is a prescription medication used to treat various types of cancer by inhibiting the programmed death-1 (PD-1) pathway.

Bristol Myers Squibb – Oncology Treatments

Domain: pharmaphorum.com

Registered: 2009 ( 16 years )

Introduction: Bristol Myers Squibb (BMS) has received FDA approval for a new treatment for non-small cell lung cancer (NSCLC), enhancing its competitive position in the oncology market.

Vivoinfusion – Cancer Immunotherapy Solutions

Domain: vivoinfusion.com

Registered: 2022 ( 3 years )

Introduction: Opdivo® (nivolumab) is a checkpoint inhibitor immunotherapy used to treat various types of cancer by enhancing the immune system’s ability to recognize and attack cancer cells.

FDA – Cancer Treatment Injections

Domain: fda.gov

Registered: 2000 ( 25 years )

Introduction: Nivolumab and hyaluronidase (NVHY) is a subcutaneous injection approved for use in patients with certain types of cancer.

Ono Pharma – Cancer Treatment Solutions

Domain: ono-pharma.com

Registered: 2015 ( 10 years )

Introduction: Ono Pharmaceutical Co., Ltd. offers Opdivo® (nivolumab) Intravenous Infusion and Yervoy® (ipilimumab) Injection as combination therapy for the treatment of unresectable hepatocellular carcinoma (HCC) in Japan.

Ema – Oncology Treatments and Cancer Care Solutions

Domain: ema.europa.eu

Registration year: Not available

Introduction: Opdivo is a cancer medicine used to treat various types of cancer including melanoma, non-small cell lung cancer (NSCLC), advanced renal cell carcinoma, classical Hodgkin lymphoma, squamous cell cancer of the head and neck, urothelial cancer, and malignant pleural mesothelioma.

Asbestos – Cancer Immunotherapy Solutions

Domain: asbestos.com

Registered: 1995 ( 30 years )

Introduction: Opdivo is an immunotherapy drug used to treat various types of cancer by enhancing the body’s immune response against cancer cells.

Dir – Nivolumab Injection for Cancer Treatment

Domain: dir.indiamart.com

Registered: 1996 ( 29 years )

Introduction: Nivolumab injection (Opdyta) used for treating various cancers including skin, lung, and kidney cancer.

Exportersindia – Nivolumab Injections for Cancer Treatment

Domain: exportersindia.com

Registered: 1997 ( 28 years )

Introduction: The company primarily offers Nivolumab injections, including various formulations such as Opdivo and Opdyta, used for treating different types of cancers.

Healthline – Cancer Immunotherapy Solutions

Domain: healthline.com

Registered: 2004 ( 21 years )

Introduction: Opdivo (nivolumab) is a prescription immunotherapy drug used to treat various cancers in adults and certain children.

Rxpharmacycoupons – Opdivo Manufacturer Coupons

Domain: rxpharmacycoupons.com

Registered: 2011 ( 14 years )

Introduction: Opdivo is a prescription medication offered by Bristol-Myers Squibb for cancer treatment, with manufacturer coupons available to reduce patient costs.

PrescriptionGiant – Prescription Savings Program

Domain: prescriptiongiant.com

Registered: 2005 ( 20 years )

Introduction: PrescriptionGiant offers a free prescription savings program that helps patients save on their prescription medications, including Opdivo, with discounts of up to 75%.

Bristol Myers Squibb – Liver Cancer Immunotherapy Solutions

Domain: fiercepharma.com

Registered: 2007 ( 18 years )

Introduction: Bristol Myers Squibb offers a combination immunotherapy treatment for first-line liver cancer, following competitors Roche and AstraZeneca.

Medicines – Cancer Treatment Solutions

Domain: medicines.org.uk

Registered: 1999 ( 26 years )

Introduction: OPDIVO 10 mg/mL concentrate for solution for infusion, containing nivolumab, indicated for various types of cancer treatment.

Pharmacompass – Active Pharmaceutical Ingredients Solutions

Domain: pharmacompass.com

Registered: 2014 ( 11 years )

Introduction: Opdivo is an active pharmaceutical ingredient (API) with multiple suppliers and is involved in various finished dosage formulations (FDFs) across different regulatory regions.

Category Information

The keyword ‘Opdivo manufacturer’ refers to the pharmaceutical company responsible for producing Opdivo, a medication primarily used in cancer treatment. Opdivo, generically known as nivolumab, is an immune checkpoint inhibitor that helps the body’s immune system recognize and attack cancer cells. The manufacturer of Opdivo plays a crucial role in the development, production, and distribution of this medication, ensuring that it meets rigorous safety and efficacy standards set by health authorities.

The significance of the manufacturer in this context extends beyond mere production; it encompasses research and development, regulatory compliance, and post-market surveillance. Pharmaceutical manufacturers invest heavily in clinical trials to validate the drug’s effectiveness and safety, which is critical for patient outcomes. Moreover, understanding the manufacturer’s practices can shed light on the quality of the drug, its accessibility, and its role in the broader landscape of cancer therapies.

Application Information

Opdivo, manufactured by Bristol-Myers Squibb, is an immune checkpoint inhibitor primarily used in oncology. Its application spans several critical areas within cancer treatment. Firstly, it is extensively employed in the treatment of various cancers, including melanoma, lung cancer, and renal cell carcinoma, enhancing the immune system’s ability to recognize and attack cancer cells. Secondly, Opdivo is utilized in combination therapies, often paired with other agents to improve efficacy and patient outcomes, particularly in advanced-stage cancers.

Additionally, Opdivo plays a significant role in clinical trials aimed at exploring new treatment regimens and expanding its indications. Its use in personalized medicine is also notable, as healthcare providers tailor treatments based on individual patient profiles, aiming for better effectiveness and fewer side effects. Overall, Opdivo is instrumental in advancing cancer care and improving survival rates.

Production Process Information

The production process for Opdivo, a cancer treatment medication, involves several key stages that ensure the drug is safe and effective. First, research and development (R&D) is conducted to discover and refine the drug’s active ingredients. This phase includes extensive laboratory testing to understand how the drug works and its potential effects on cancer cells. Once R&D is complete, the next step is clinical trials.

These trials are conducted in multiple phases to test the drug on human volunteers, ensuring its safety and efficacy. If successful, the drug then undergoes regulatory approval, where health authorities review the data before it can be marketed. Finally, once approved, the drug enters the manufacturing phase, where it is produced in large quantities under strict quality control standards. This ensures each batch meets safety requirements before reaching pharmacies and hospitals for patient use.

Related Video

Frequently Asked Questions (FAQs)

What should I look for in an Opdivo manufacturer?
When searching for an Opdivo manufacturer, it’s essential to consider several factors. First, ensure that the manufacturer is compliant with relevant regulatory standards, such as Good Manufacturing Practices (GMP). Look for a factory with a solid track record in producing oncology medications, as experience in this field is crucial. Additionally, consider their quality control processes, production capacity, and whether they have the necessary certifications. Engaging in discussions about their supply chain and sourcing of raw materials can also provide insights into their reliability and commitment to quality.

How can I verify the credibility of an Opdivo manufacturer?
To verify the credibility of a potential Opdivo manufacturer, start by checking their certifications and licenses. You can request documentation that proves their compliance with international standards. It’s also helpful to look for reviews or testimonials from other clients who have worked with them. Networking within industry forums or attending pharmaceutical trade shows can connect you with others who have firsthand experience with the manufacturer. Lastly, consider conducting a site visit to see the facilities and operations in person, which can give you a clearer picture of their capabilities.

What questions should I ask a potential Opdivo manufacturer?
When interviewing a potential Opdivo manufacturer, ask about their production processes, quality assurance measures, and how they handle regulatory compliance. Inquire about their experience with similar products and their ability to scale production if needed. It’s also important to discuss lead times, minimum order quantities, and pricing structures. Additionally, ask about their approach to handling any potential issues, such as recalls or quality concerns, to gauge their responsiveness and reliability.

What are the common challenges in finding an Opdivo manufacturer?
One of the common challenges in finding an Opdivo manufacturer is ensuring that they meet stringent regulatory requirements, which can vary by region. Additionally, manufacturers may have limited capacity or long lead times, making it difficult to align with your production schedule. Quality assurance can also be a concern, as not all manufacturers maintain the same standards. Finally, communication barriers can arise, especially if the manufacturer is located in a different country, which can complicate negotiations and oversight.

How can I establish a good relationship with my Opdivo manufacturer?
Building a strong relationship with your Opdivo manufacturer is key to a successful partnership. Start by maintaining open and transparent communication, sharing your expectations clearly from the outset. Regular check-ins and updates can help keep both parties aligned. Be respectful of their processes and timelines, and show appreciation for their efforts. Additionally, consider collaborating on quality improvement initiatives or joint problem-solving when challenges arise. A positive, collaborative approach fosters trust and can lead to a more fruitful partnership.

Similar Posts